Diffuse morbilliform eruption after consumption of ginkgo biloba supplement

Residual Burden in Adalimumab-Treated Patients with Hidradenitis Suppurativa: An Observational Cohort Study Based on Insurance Claims in the USA.

Drugs - real world outcomes·2026

Atopic Dermatitis Across the Lifespan: Understanding, Measuring and Minimizing Cumulative Life Course Impairment.

Acta dermato-venereologica·2026

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.

JAMA dermatology·2026

Therapeutic drug monitoring of adalimumab in hidradenitis suppurativa: a prospective observational study.

Frontiers in immunology·2026

Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.

Dermatology and therapy·2025

Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.

Journal of the American Academy of Dermatology·2025

Alopecia areata: Emerging therapies and up-to-date management strategies.

Journal of the American Academy of Dermatology·2026

VEXAS Syndrome: A Comprehensive Review for Dermatologists Part 1: Epidemiology, Pathophysiology, and Clinical Presentations.

Journal of the American Academy of Dermatology·2026

VEXAS Syndrome: A Comprehensive Review for Dermatologists Part 2: Work-up, Diagnosis, Treatment, and Prognosis.

Journal of the American Academy of Dermatology·2026

Alopecia Areata: Advances in Clinical Evaluation and Pathogenesis.

Journal of the American Academy of Dermatology·2026

Molecular Alterations in Patients of Color with Advanced Cutaneous and Unknown Primary Melanomas.

Journal of the American Academy of Dermatology·2026

Relapse of Alopecia Areata During Ongoing JAK Inhibitor Therapy Is Not Uncommon and Usually Occurs in Previously Affected Areas: A Multicentre Italian Real-World Study.

Journal of the American Academy of Dermatology·2026

Single-atom catalysts anchored on nanostructured frameworks for high-performance lithium-sulfur batteries: a review of catalytic mechanisms.

RSC advances·2026

Trace sulfaguanidine additives enabling the development of stable Zn anodes for long life zinc-ion batteries.

Chemical communications (Cambridge, England)·2026

Recent Interface Interactions Engineering in MXene Composite Cathodes for Enhanced Zinc-Ion Batteries.

Small methods·2026

Interfacial engineering of in situ grown porous aromatic framework integrated electrodes for electrochemical nitric oxide reduction.

Journal of colloid and interface science·2026

Few-Layer MoS2-Decorated MoO2 for High-Density Exposed Catalytic Heterointerfaces in Lithium-Sulfur Batteries.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026

Endoscopic Removal of Non-Eroding Gastric Bands Post Silastic Ring Vertical Gastroplasty Using Lumen-Apposing Metal Stents-a Case Series.

Obesity surgery·2026

Related Experiment Videos

Diffuse morbilliform eruption after consumption of ginkgo biloba supplement

Related Concept Videos

Residual Burden in Adalimumab-Treated Patients with Hidradenitis Suppurativa: An Observational Cohort Study Based on Insurance Claims in the USA.

Atopic Dermatitis Across the Lifespan: Understanding, Measuring and Minimizing Cumulative Life Course Impairment.

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.

Therapeutic drug monitoring of adalimumab in hidradenitis suppurativa: a prospective observational study.

Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.

Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.

Alopecia areata: Emerging therapies and up-to-date management strategies.

VEXAS Syndrome: A Comprehensive Review for Dermatologists Part 1: Epidemiology, Pathophysiology, and Clinical Presentations.

VEXAS Syndrome: A Comprehensive Review for Dermatologists Part 2: Work-up, Diagnosis, Treatment, and Prognosis.

Alopecia Areata: Advances in Clinical Evaluation and Pathogenesis.

Molecular Alterations in Patients of Color with Advanced Cutaneous and Unknown Primary Melanomas.

Relapse of Alopecia Areata During Ongoing JAK Inhibitor Therapy Is Not Uncommon and Usually Occurs in Previously Affected Areas: A Multicentre Italian Real-World Study.

Single-atom catalysts anchored on nanostructured frameworks for high-performance lithium-sulfur batteries: a review of catalytic mechanisms.

Trace sulfaguanidine additives enabling the development of stable Zn anodes for long life zinc-ion batteries.

Recent Interface Interactions Engineering in MXene Composite Cathodes for Enhanced Zinc-Ion Batteries.

Interfacial engineering of in situ grown porous aromatic framework integrated electrodes for electrochemical nitric oxide reduction.

Few-Layer MoS2-Decorated MoO2 for High-Density Exposed Catalytic Heterointerfaces in Lithium-Sulfur Batteries.

Endoscopic Removal of Non-Eroding Gastric Bands Post Silastic Ring Vertical Gastroplasty Using Lumen-Apposing Metal Stents-a Case Series.

Related Experiment Videos

Diffuse morbilliform eruption after consumption of ginkgo biloba supplement

Related Concept Videos

Related Articles